Lapovis

Latanoprost, the active ingredient in Lapovis, is a prostaglandin analog presented as an eye‑drop formulation for ocular use. It is prescribed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, thereby helping to preserve visual function. The product meets European Union regulatory standards and is supplied as a prescription‑only medication.

GNH USA supplies Lapovis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, eye‑care clinics and procurement teams worldwide, with capabilities for regulated export and quality assurance.

Latanoprost is a prostaglandin analog used to manage conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent development of glaucoma. Secondary glaucoma (e.g., pseudoexfoliative): helps control pressure when prostaglandin response is appropriate. Normal‑tension glaucoma: provides pressure reduction even within normal range. Post‑surgical ocular hypertension: assists in managing pressure spikes after eye surgery.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye itching: pruritus of the ocular surface. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual brownish pigmentation. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea. - Severe allergic reaction: swelling, rash, or anaphylaxis. - Sudden loss of vision: rapid decrease in visual acuity.

Clinicians should consider several precautions before initiating Latanoprost therapy.

Pregnancy: safety not established; avoid unless benefit outweighs risk. Breastfeeding: unknown excretion; use with caution. Concomitant ocular inflammation: may exacerbate uveitis; monitor closely. Contact lens wearers: may cause deposits; advise removal before use. Allergy to prostaglandin analogs: contraindicated. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Prostaglandin analog combination: additive pressure‑lowering effect may cause hypotony. - Non‑steroidal anti‑inflammatory eye drops: may reduce efficacy. - Systemic carbonic anhydrase inhibitors: increased risk of ocular side effects.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive IOP reduction; monitor pressure. - Alpha‑agonist eye drops: potential synergistic effect. - Systemic corticosteroids: may diminish prostaglandin response.